Clinical trial
PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial
NCT02382016
Study timeline
Study start (actual)2015-06-23Date precision: day
Registry last updated2025-03-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Portopulmonary Hypertensionunresolved
Interventions
MacitentanDRUG · verified · RxNorm: macitentan
PlaceboOTHER
Sponsors & collaborators
Actelionlead sponsor
Mapped research locations
Los AngelesCalifornia, United States2DallasTexas, United States2JacksonvilleFlorida, United States2PragueCzechia2HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San AntonioTexas, United States1San FranciscoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02382016 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.